A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos) - 23/08/11
Reprint requests: Stefan Seewald, MD, Department of Interdisciplinary Endoscopy, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.Hamburg, Germany, Cairo, Egypt
Abstract |
Background |
N-butyl-2-cyanoacrylate has been successfully used for the treatment of bleeding from gastric fundal varices (FV). However, significant rebleeding rates and serious complications including embolism have been reported.
Objective |
Our purpose was to analyze the safety and efficacy of N-butyl-2-cyanoacrylate for FV bleeding by using a standardized injection technique and regimen.
Design |
Retrospective.
Setting |
Two tertiary referral centers.
Patients |
A total of 131 patients (91 men/40 women) with FV underwent obliteration with N-butyl-2-cyanoacrylate by a standardized technique and regimen.
Interventions |
(1) Dilution of 0.5 mL of N-butyl-2-cyanoacrylate with 0.8 mL of Lipiodol, (2) limiting the volume of mixture to 1.0 mL per injection to minimize the risk of embolism, (3) repeating intravariceal injections of 1.0 mL each until hemostasis was achieved, (4) obliteration of all tributaries of the FV, (5) repeat endoscopy 4 days after the initial treatment to confirm complete obliteration of all visible varices and repeat N-butyl-2-cyanoacrylate injection if necessary to accomplish complete obliteration.
Main Outcome Measurements |
Immediate hemostasis rate, early rebleeding rate, bleeding-related mortality rate, procedure-related complications, long-term cumulative rebleeding-free rate, and cumulative survival rate.
Results |
Initial hemostasis and variceal obliteration were achieved in all patients. The mean number of sessions was 1 (range 1-3). The mean total volume of glue mixture used was 4.0 mL (range 1-13 mL). There was no occurrence of early FV rebleeding, procedure-related complications, or bleeding-related death. The cumulative rebleeding-free rate at 1, 3, and 5 years was 94.5%, 89.3%, and 82.9%, respectively.
Conclusion |
Obliteration of bleeding FV with N-butyl-2-cyanoacrylate is safe and effective with use of a standardized injection technique and regimen.
Le texte complet de cet article est disponible en PDF.Abbreviations : B-RTO, EIS, B-RTP-EIS, EV, EVL, FV, GOV, GRS, GV, IGV, HVPG, TIPS
Plan
| Presented at Digestive Disease Week, May 2005, Chicago, Illinois, USA (Gastrointest Endosc 2005;61:AB91). |
|
| See CME section; p. 532. |
Vol 68 - N° 3
P. 447-454 - septembre 2008 Retour au numéro
Article précédent
- The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage
- Samuel Herrera, Josep M. Bordas, Josep Llach, Angels Ginès, Maria Pellisé, Glòria Fernández-Esparrach, Fernando Mondelo, Alfredo Mata, Andres Cárdenas, Antoni Castells
- Endoscopic transpapillary gallbladder drainage in patients with acute cholecystitis in whom percutaneous transhepatic approach is contraindicated or anatomically impossible (with video)
- Takao Itoi, Atsushi Sofuni, Fumihide Itokawa, Takayoshi Tsuchiya, Toshio Kurihara, Kentaro Ishii, Shujiro Tsuji, Nobuhito Ikeuchi, Sakiko Tsukamoto, Mani Takeuchi, Takashi Kawai, Fuminori Moriyasu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?